Aberrant hypomethylation has been hypothesized to contribute to cancer progression by activating oncogenes such as h-RAS, r-RAS, c-MYC, and c-FOS[11]–[13], by retrotransposon activation [14]–[16] or by increasing chromosome instability as in ICF syndrome [17]. This evidence concerns the gene MYC and cancer.